BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31423638)

  • 1. Drug reaction with eosinophilia and systemic symptoms: Pediatric case series and literature review.
    Oberlin KE; Rahnama-Moghadam S; Alomari AK; Haggstrom AN
    Pediatr Dermatol; 2019 Nov; 36(6):887-892. PubMed ID: 31423638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Series of 49 French Pediatric Cases.
    Bedouelle E; Ben Said B; Tetart F; Milpied B; Welfringer-Morin A; Maruani A; Catteau B; Dezoteux F; Staumont-Sallé D; Mazereeuw-Hautier J; Abasq C; Chiaverini C; Delaunay J; Mallet S; Sterling B; Puzenat E; Raynal M; Collet E; Bernier C;
    J Allergy Clin Immunol Pract; 2022 Jan; 10(1):267-274.e5. PubMed ID: 34332174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature.
    Metterle L; Hatch L; Seminario-Vidal L
    Pediatr Dermatol; 2020 Jan; 37(1):124-129. PubMed ID: 31691347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management and Long-Term Outcomes of Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) in Children: A Scoping Review.
    Cherepacha N; St George-Hyslop F; Chugani B; Alabdeen Y; Sanchez-Espino LF; Mahood Q; Sibbald C; Verstegen RHJ
    Am J Clin Dermatol; 2024 Jul; 25(4):609-621. PubMed ID: 38755503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome associated with cefotaxime and clindamycin use in a 6 year-old boy: a case report.
    Karakayalı B; Yazar AS; Çakir D; Cetemen A; Kariminikoo M; Deliloglu B; Guven S; Islek I
    Pan Afr Med J; 2017; 28():218. PubMed ID: 29629004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug reaction with eosinophilia and systemic symptoms in a child on multiple antiepileptics.
    Goswami JN; Vaidya PC; Saini AG; De D; Radotra BD; Singhi PD
    Turk J Pediatr; 2017; 59(2):197-199. PubMed ID: 29276875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug rash with eosinophilia and systemic symptoms syndrome masquerading as a lymphoproliferative disorder in a young adult on immunosuppressive therapy for rheumatoid arthritis: a case report.
    Hyser E
    J Med Case Rep; 2022 Sep; 16(1):336. PubMed ID: 36059007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late sequelae of drug reaction with eosinophilia and systemic symptoms (DRESS) cause thyroid dysfunction and thyroiditis: review of literature.
    Tempark T; Deekajorndech T; Chatproedprai S; Supornsilchai V; Wananukul S
    J Pediatr Endocrinol Metab; 2022 May; 35(5):567-575. PubMed ID: 35119800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug reaction with eosinophilia and systemic symptoms (DRESS) and its relation with autoimmunity in a reference center in Mexico.
    Matta JM; Flores SM; Cherit JD
    An Bras Dermatol; 2017; 92(1):30-33. PubMed ID: 28225953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug reaction with eosinophilia and systemic symptoms in a cohort of Asian children.
    Han XD; Koh MJ; Wong SMY
    Pediatr Dermatol; 2019 May; 36(3):324-329. PubMed ID: 30920020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug reaction with eosinophilia and systemic symptoms (DRESS): A tertiary care centre retrospective study.
    Del Pozzo-Magaña BR; Rieder MJ; Garcia-Bournissen F; Lazo-Langner A
    Br J Clin Pharmacol; 2022 Sep; 88(9):4134-4141. PubMed ID: 35421262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxacillin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
    Sharpe A; Mourad BM; Hardwick CJ; Reilly T; Dweck E; Bondarsky E
    Am J Case Rep; 2019 Mar; 20():345-348. PubMed ID: 30877266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug reaction with eosinophilia and systemic symptoms: A single center descriptive observational study.
    Sandhu S; Neema S; Vashisht D; Venugopal R; Sengupta P; Radhakrishnan S
    Dermatol Ther; 2021 Jan; 34(1):e14670. PubMed ID: 33314590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug reaction with eosinophilia and systemic symptoms may occur within 2 weeks of drug exposure: A retrospective study.
    Soria A; Bernier C; Veyrac G; Barbaud A; Puymirat E; Milpied B
    J Am Acad Dermatol; 2020 Mar; 82(3):606-611. PubMed ID: 31562941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
    Kano Y; Tohyama M; Aihara M; Matsukura S; Watanabe H; Sueki H; Iijima M; Morita E; Niihara H; Asada H; Kabashima K; Azukizawa H; Hashizume H; Nagao K; Takahashi H; Abe R; Sotozono C; Kurosawa M; Aoyama Y; Chu CY; Chung WH; Shiohara T
    J Dermatol; 2015 Mar; 42(3):276-82. PubMed ID: 25623158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-Trimoxazole-Induced DRESS Syndrome: A Case Report.
    Paitorn L
    J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S227-30. PubMed ID: 27266243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to identify DRESS, drug reaction with eosinophilia and systemic symptoms?
    Sarajärvi P; Kubin M; Tasanen K; Huilaja L
    Duodecim; 2017; 133(1):43-51. PubMed ID: 29199808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug reaction with eosinophilia and systemic symptoms: observations from a tertiary care institution.
    Sasidharanpillai S; Riyaz N; Rajan U; Binitha MP; Khader A; Mariyath OK; John R; Puravoor J
    Indian J Dermatol Venereol Leprol; 2014; 80(3):221-8. PubMed ID: 24823399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric drug reaction with eosinophilia and systemic symptoms: A 12-year retrospective study in a tertiary center.
    Chatproedprai S; Tiasiri N; Chantawarangkul K; Wananukul S
    J Dermatol; 2024 Apr; 51(4):509-517. PubMed ID: 38214543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature, with a focus on relapsing cases.
    Afiouni R; Zeinaty P; Kechichian E; Zoghaib S; Matar S; Helou-Mallat J; Tomb R
    Pediatr Dermatol; 2021 Jan; 38(1):125-131. PubMed ID: 33155729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.